Mercado global de recubrimientos y superficies antimicrobianos inteligentes para el cuidado de la salud: tendencias de la industria y pronóstico hasta 2030

Análisis y tamaño del mercado de superficies y recubrimientos antimicrobianos inteligentes para el cuidado de la salud

Un revestimiento antimicrobiano es una cubierta de superficie que contiene un ingrediente activo eficaz contra el crecimiento de bacterias y hongos. Los revestimientos antimicrobianos pueden incluir revestimientos a base de solventes, agua, líquidos o en polvo . Las economías en desarrollo y las crecientes inversiones en investigación y desarrollo están impulsando el mercado y creando oportunidades para la innovación y la expansión del mercado.                      

Data Bridge Market Research analiza que el mercado global de recubrimientos y superficies antimicrobianos inteligentes para el cuidado de la salud, que fue de USD 10 150,00 millones en 2022, y se espera que alcance los USD 28 953,75 millones para 2030, y se espera que experimente una CAGR del 14,00 % durante el período de pronóstico. Las "instalaciones de atención médica" dominan el segmento de aplicaciones del mercado de recubrimientos y superficies antimicrobianos inteligentes para el cuidado de la salud debido a la creciente demanda de recubrimientos antimicrobianos para recubrimientos y superficies antimicrobianos inteligentes para el cuidado de la salud. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research incluyen un análisis profundo de expertos, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado de recubrimientos y superficies antimicrobianos inteligentes para el cuidado de la salud

Market Definition

Smart antimicrobial coatings and surfaces are used to reduce the spread of germs and infections.  In the healthcare sector, the coatings minimize the risk of infection during medical procedures. Smart antimicrobial healthcare coatings and surfaces are used on various medical tools and products such as catheters, surgical devices, medical electronics, medical instruments, trays, among others and are also used in equipment such as textiles, masks, gloves, and carpeting.

Global Smart Antimicrobial Healthcare Coatings and Surfaces Market Dynamics

Drivers

• Increasing prevalence of chronic diseases

The globally increasing burden of chronic diseases such as cancer, diabetes, cardiovascular diseases, and autoimmune diseases is a major driver of the protein therapy market. Protein-based therapies offer targeted therapeutic options with high specificity and efficacy, making them valuable in the management and treatment of these complex diseases.

• Technological advancements in microbiology

Advances in microbiology, including recombinant DNA technology, monoclonal antibody production, and protein expression systems, have revolutionized the development of Smart Antimicrobial Healthcare Coatings and Surfaces. These technological advancements have enabled the production of highly specific and potent protein drugs with improved pharmacokinetics and reduced immunogenicity.

• Increasing demand for personalized medicine

The demand for personalized medicine is increasing, which requires tailoring treatment based on a person's genetic profile, disease characteristics, and response to treatment. Protein drugs, such as monoclonal and bispecific antibodies, can be tailored to target specific molecular targets, enabling individualized and precise therapies.

Opportunities

• Rising demand for targeted therapies

There is a demand for targeted therapies that offer high specificity and efficacy in treating various diseases. Protein therapies, such as monoclonal antibodies and fusion proteins, offer targeted approaches by binding specifically to disease-related targets, leading to improved treatment outcomes. This gives the market an opportunity to develop and commercialize new protein-based drugs that target specific diseases.

• Expansion in emerging markets

Emerging markets such as China, India, Brazil and other countries in Asia and Latin America are seeing significant increases in healthcare spending and access to advanced treatments. The expansion creates a favorable market environment for protein therapy, as these areas offer untapped potential and large patient populations. Protein drugs can be adapted and tailored to the specific needs of these markets, thus increasing market reach and revenue.

Restraints

• High development and manufacturing costs

Development and manufacturing of protein drugs involves complex processes, extensive research, and strict quality control measures. This results in high expenditure on research and development, manufacturing and regulatory compliance. High costs significantly limit the market and the availability and affordability of protein-based therapies, especially in resource-constrained healthcare systems.

• Stringent regulatory requirements

Protein therapeutic preparations are subject to strict requirements for safety, efficacy, and quality. Regulatory agencies set strict guidelines and standards for their development, testing, and approval. Compliance with these regulatory requirements can be time-consuming, expensive, and resource-intensive, resulting in delays in product development and time-to-market. A strict regulatory environment restricts the market, especially for small and medium-sized biopharmaceutical companies with limited resources.

Challenges

• Manufacturing complexity and scalability

Antimicrobial coatings often require complex manufacturing processes, including cell culture, expression, purification, and formulation. Achieving consistent quality, scalability and cost-effectiveness in mass production can be challenging. Manufacturing challenges can limit the availability and affordability of these surfaces, particularly in treating rare or rare diseases. Overcoming manufacturing complexities and building strong manufacturing capabilities are critical for market growth and accessibility.

• Intellectual property and patent expiration

Intellectual property rights and patent protection are vital in the protein medicine market. The industry faces patent expiration challenges as many pioneering protein therapies are nearing the end of their patent exclusivity. This allows biosimilars and generic versions to enter the market, increasing competition and potential price erosion. Companies must focus on developing innovative protein-based therapies and generate new patents to maintain a competitive advantage.

Recent Development

• In June 2022, DuPont has announced completion of the previously-announced sale of its Biomaterials business unit to the Huafon Group for a purchase price of approximately USD 240 million

Global Smart Antimicrobial Healthcare Coatings and Surfaces Market Scope

The global smart antimicrobial healthcare coatings and surfaces market is segmented on the basis of type and application. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Silver and nanosilver
• Hydrogels
• Chitosan
• Silanes
• Sulfates
• Graphene
• Carbon Nanotubes

Application

• Healthcare facilities
• Medical Implants
• Surgical Equipment
• Veterinary
• Laboratory equipment

Global Smart Antimicrobial Healthcare Coatings and Surfaces Market Regional Analysis/Insights

The global smart antimicrobial healthcare coatings and surfaces market is analyzed and market size insights and trends are provided by country, product, application, function, and end user as referenced above.

The countries covered in the global smart antimicrobial healthcare coatings and surfaces market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East and Africa.

North America is expected to dominatethe global smart antimicrobial healthcare coatings and surfaces market due to the adoption of advanced technology along with the prevalence of favorable reimbursement policies and improved standard of living of the people.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the increasing demand for advanced treatment options along andwith rising per capita income.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

El mercado global de recubrimientos y superficies antimicrobianos inteligentes para el cuidado de la salud también le proporciona un análisis detallado del mercado para cada país: el crecimiento del gasto en atención médica para equipos de capital, la base instalada de diferentes tipos de productos para el mercado de recubrimientos y superficies antimicrobianos inteligentes para el cuidado de la salud, el impacto de la tecnología que utiliza curvas de línea de vida y los cambios en los escenarios regulatorios de la atención médica y su impacto en el mercado de recubrimientos y superficies antimicrobianos inteligentes para el cuidado de la salud. Los datos están disponibles para el período histórico 2015-2020.

Análisis del panorama competitivo y de la cuota de mercado de los recubrimientos y superficies antimicrobianos inteligentes para el sector sanitario

El panorama competitivo del mercado global de recubrimientos y superficies antimicrobianos inteligentes para el cuidado de la salud proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y la variedad de productos y el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado global de recubrimientos y superficies antimicrobianos inteligentes para el cuidado de la salud.

Algunos de los principales actores que operan en el mercado global de superficies y recubrimientos antimicrobianos inteligentes para el cuidado de la salud son:

• AkzoNobel NV (Países Bajos)
• Corporación de acero AK (India)
• Lonza (Suiza)
• Diamond Vogel (Estados Unidos)
• DuPont (Estados Unidos)
• Sistemas de recubrimiento Axalta (EE. UU.)
• Nippon Paint Holdings Co., Ltd. (India)
• PPG Industries, Inc. (Estados Unidos)
• RPM International Inc. (Estados Unidos)
• Koninklijke DSM NV (Países Bajos)
• Recubrimientos industriales Burke (Estados Unidos)
• La empresa Sherwin-Williams (Estados Unidos)
• Corporación Troy (Estados Unidos)

SKU-65422